Long-Term Safety and Disease Control With Ruxolitinib Cream Among Patients With Atopic Dermatitis Based on Previous Medication History: Pooled Results from Two Phase 3 Studies. J of Skin 2021, 5 (6), s65. https://doi.org/10.25251/skin.5.supp.65.